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ABSTRACT  The  interaction  of  migrating  newt  epidermal  cells  with  the  extracellular  matrix 
protein,  fibronectin,  was studied.  Pieces of nitrocellulose coated with  intact human  plasma 
fibronectin or proteolytically derived fragments  were implanted  into wounded limbs  so that 
the coated nitrocellulose served as wound bed for migrating epidermal cells as they attempted 
to form  a wound  epithelium.  Epidermal  cells  migrated  very poorly on nitrocellulose pieces 
coated with (a) a 27-kD amino-terminal heparin-binding fragment,  (b) a 46-kD gelatin-binding 
fragment,  (c) a combined  33- and 66-kD carboxy-terminal  heparin-binding preparation  rep- 
resenting  peptide  sequences  in  the A  and  B chains,  respectively,  or (d) a 31-kD  carboxy- 
terminal fragment from the A chain, containing a free sulfhydryl group. In contrast,  epidermal 
cells readily migrated onto nitrocellulose coated with a mixture of fragments  from the middle 
of the molecule (80-125kD) that bind neither heparin nor gelatin. Attempts to block migration 
on fibronectin-coated  nitrocellulose using  1810, a monoclonal antibody that blocks Chinese 
hamster  ovary  cell  attachment  to  fibronectin,  were  unsuccessful  despite  saturation  of the 
epitope against which I810 is directed. In contrast,  a polyclonal anti-fibronectin antibody did 
inhibit migration. These results show that the ability of fibronectin to support newt epidermal 
cell migration is not shared equally by all regions of the molecule, but is restricted to a domain 
in the middle third. They also suggest that the site supporting migration is separate and distinct 
from the site mediating Chinese hamster ovary cell attachment. 
Fibronectin is a complex blood-plasma glycoprotein which is 
also found in the pericellular matrix on the surface of certain 
cell  types.  It is  composed of two  similar  but  perhaps  not 
totally identical high molecular mass polypeptides (21), inter- 
connected by disulfide bonds near the carboxy-terminal end 
(30). Distributed along the molecule is a cross-linking site for 
transglutaminase (18), as well as binding sites for collagen (l, 
l 1),  several glycosaminoglycans (24,  26,  32),  Staphylococci 
(18,  29),  and certain types of eucaryotic cells (10,  22,  25). 1 
Through this organization into a series of structural domains 
which bind specific ligands, fibronectin participates in various 
biological activities. In wounds, plasma fibronectin is cross- 
linked to fibrin during clot formation (9,  16,  17). This im- 
mobilized fibronectin apparently is then used as a migration 
substrate by fibroblasts as they invade the clot (10). 
Hasty, D. L., H. S. Courtney, W. A. Simpson, J. A. McDonald, and 
E. H. Beachey, manuscript submitted for publication. 
Until recently it appeared that fibronectin might not sup- 
port attachment and spreading of epithelial cells (6,  19, 28). 
But there have now been several reports showing that fibro- 
nectin can mediate the adhesion of epithelial cells to tissue 
culture plastic (8,  15,  33) and two reports that epithelial cell 
migration is enhanced in the presence of fibronectin (3, 20). 
These observations and the fact that the same fibrin-fibro- 
nectin clot that provides a matrix for fibroblast migration into 
a wound also serves as a substrate for epithelial cells as they 
migrate to cover the wound (2) suggest  that epithelial-fibro- 
nectin interactions may play an important role in restoration 
of epithelial integrity following its loss. 
We  have  recently developed a  method  for studying the 
interaction of epidermal cells with various macromolecules in 
wounded amphibian limbs which have been amputated and 
explanted into a  dish  of saline solution  (5).  In this system, 
pieces ofpolycarbonate filter, coverslip glass, or nitrocellulose, 
coated with various substances, are implanted under one edge 
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© The Rockefeller University Press - 0021-9525/85/07/0073f06  $1.00 FIGURE  I  Test system for analyzing the ability of protein-coated nitrocellulose to support epidermal cell migration.  I- x  2-ram 
pieces of nitrocellulose were inserted  (one per wound) under the anterior edge of a rectangular  skin wound on newt limbs 
explanted to a dish of HS (amphibian saline). 10 h later,  the limbs  were fixed, stained  briefly in 0.1% crystal violet, and the 
implant and any wound epithelium on it were drawn with the aid of a drawing tube-equipped microscope.  Using a planimeter, 
the area covered by wound epithelium was then determined from  a standardized  region  of each  implant (relative  distance 
migrated). In the figure, the lower implant (fibronectin coated) carries a substantial wound epithelium (arrow), whereas the upper 
one (PBS coated) has allowed no epidermal migration. (For photographic purposes the limbs in this figure were stained with eosin 
and methylene blue.) x-17. 
of a  fresh  skin  wound  so that  epidermal  cells attempting  to 
form a  wound  epithelium  must encounter  the implant.  Using 
this model, we recently demonstrated  that epidermal cells will 
readily  migrate  over  fibronectin-coated  implants  (3).  In  the 
present  study  we  have  attempted  to  localize  the  domain  of 
fibronectin that mediates this migration. 
MATERIALS  AND  METHODS 
Animals:  Adult male newts (Notophthalmus viridescens) were obtained 
from  Connecticut Valley  Biological,  Southampton, MA.  Details of animal 
maintenance have been described previously (3). 
Wounding,  Nitrocellulose  Implantation,  and  Migration 
Measurement:  Rectangular wounds (1.5  x  3.0 ram) were  made by re- 
moving a piece of skin from the dorsal surface of each hind limb between the 
knee and ankle. Wounded limbs were then amputated through the thigh and 
explanted into Holtfreter solution (HS)  2 (0.06  M  sodium chloride,  0.6 mM 
potassium chloride,  0.9 mM calcium chloride,  2.3 mM sodium bicarbonate, 
0.005%  [wt/vol]  streptomycin sulfate).  After the clotted  blood  was cleaned 
from each wound, the limbs were transferred to fresh HS and one end of a  l- 
x  2-ram piece of nitrocellulose was then inserted under the skin at the anterior 
2  Abbreviations used in this paper.  anti-FN,  polyclonal  antibodies 
against  human  plasma  fibronectin;  CHO,  Chinese  hamster ovary; 
HS, Holtfreter solution (0.06 M  sodium chloride, 0.6 mM potassium 
chloride,  0.9  mM  calcium  chloride,  2.3  mM  sodium  bicarbonate, 
0.005%  [wt/vol] streptomycin sulfate); NRK, normal rat kidney. 
wound margin (Fig.  1). The limbs were then incubated for 10 h at 23"C. After 
an overnight fxation in  10%  formalin, the epithelial  cells that had migrated 
onto the implanted nitrocellulose  were stained by immersing  the limb in 0.1% 
crystal  violet for 10 s. Using a dissecting microscope equipped with a drawing 
tube, the magnified image of the nitrocellulose  implant and its wound epithe- 
lium were  drawn on a sheet of paper.  The area occupied by a  standardized 
width of  wound epithelium was determined with a planimeter, and these values 
(relative  distance migrated) were  used to compare the ability  of various frag- 
ments of fibronectin to mediate epithelial  migration. 
Preparation  of fibronectin Fragments:  The generation and pu- 
rification  of proteolytic fragments of fibronectin has been described  in detail 
elsewhere  (see 23, 26, 27; see also Fig. 2). Briefly, gentle trypsinization with 
TPCK-trypsin (Cooper Diagnostics, Freehold,  N  J) (1% enzyme/substrate by 
weight, pH 7.2 at 37"C for 2 min) of  intact human plasma fibronectin generates 
four main fragment populations: one fragment with a molecular mass of 27 
kD and a weak affinity for heparin, arises from the amino terminal end of both 
chains of the  molecule.  A  second  low  molecular  mass fragment (31  kD) 
containing a free sulthydryl (27) originates from the A chain (12).  Two high 
molecular mass fragments (190 and 200 kD) with collagen,  heparin, and cell 
binding activity are produced from the A and B chains, respectively. Digestion 
of these last two fragments with cathepsin D (Sigma Chemical Co., St. Louis, 
MO) (1% enzyme to substrate, pH 3.1 at 37"C for 15 rain) followed by affinity 
chromatography of the  neutralized digest  over gelatin-agarose  followed  by 
heparin-sepharose, yields  four main fragment populations: a  46-kD gelatin- 
binding fragment (from  both chains), a  combined 33  and 66  kD heparin- 
binding preparation from the carboxy third of the A and B chains, respectively, 
and  finally,  a  mixture  of fragments from  the  center  of both  chains with 
molecular masses ranging from 80-125"kD. The fragments in this mixture do 
not  bind  gelatin  or  heparin,  but  do  promote  attachment,  spreading,  and 
migration of metastatic tumor cells (McCarthy, J. B., S. T. Hagen, and L. T. 
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FIGURE  2  Model of fibronectin  A  and B chains (amino-terminal  to 
the left)  showing  relative  positions  and  biological  activities  of frag- 
ments  used  in  this  study  (7,  12,  23).  /,  tryptic  cleavage  site;  x, 
catheptic  cleavage  site;  I,  peptic  cleavage site;  SH,  free  sulfhydryl 
group.  Domain  I (27 kd) has an affinity for S. aureus,  a weak affinity 
for  heparin,  and  contains  the  cross-linking  site  for  collagen/fibrin. 
Domain  II (46  kd)  has a  noncovalent  binding site for gelatin  (t). 
Domain  III  (70  kd)  binds  the  monoclonal  antibody,  180-8  (O). 
Domain  IV  (ll.5  kd)  contains a  binding site  for  the  monoclonal 
antibody, 3E3  if-q), and a cell attachment site. Domain V (33 kd) has 
a  strong affinity for heparin (I), whereas Domain VI (31  kd)  binds 
the monoclonal antibody, 2-8 ($). We tested each of the following: 
domain I; domain II; an 80-125-kD mixture from the middle of the 
molecule as shown below the  model; a  combined preparation of 
domain V from the  A  chain and  V  and  VI  from the  B chain  (the 
tryptic  site  between  domains V and  VI  in  the  A  chain  is  missing 
from the B chain [12], thus in the 33/66-kD preparation, the 33-kD 
component presumably originates from the A chain and the 66-kD 
from the B chain); and lastly,  domain VI from the A chain. 
Furcht,  manuscript in preparation).  In addition, Western transfer immunoblot 
analysis indicates that there is a peptide sequence in the mixture that binds the 
monoclonal  antibody,  3E3  (23), an antibody  that blocks normal rat  kidney 
(NRK) cell attachment to fibronectin (22). 
Coating  of Nitrocellulose  with  Fibronectin  or Fibronectin 
Fragments:  l- x  2-mm pieces of pure nitrocellulose membrane (Bio-Rad 
Laboratories,  Richmond,  CA) were coated with  10/A of either fibronectin  or 
fibronectin  fragments  diluted  to  the  desired  concentrations  in  phosphate- 
buffered saline (PBS), and air dried overnight at 23"C. To eliminate nonspecific 
interactions  between the  test cells and nitrocellulose, we treated  all implants 
for 30-40  min in HS containing  0.5% wt/vol bovine serum albumin (BSA), 
followed by 15 rain in HS. 
Binding of fibronectin and Fibronectin Fragments to Nitro- 
cellulose:  Fibronectin  and its fragments were tritiated by reductive meth- 
ylation (14). 1- x  2-ram  pieces of nitrocellulose were coated with  10 #1 (400 
ug/ml) of these radiolabeled materials as described above. After a 30-min wash 
in HS containing 0.5% wt/vol BSA, the pieces were washed for 4 h in HS (five 
changes) by which time radioactivity  leaching from them became  negligible. 
After allowing the pieces to dry overnight, bound radioactivity was determined 
by adding the  pieces individually  to Scintiverse (Fisher Scientifc  Co.,  Pitts- 
burgh, PA) and counting them in a Beckman LS 230 liquid scintillation counter 
(Beckman Instruments, lnc., Pain Alto, CA). PBS-coated pieces of nitrocellu- 
lose. processed in  the same manner as the labeled pieces, were counted  to 
determine  the level of background radiation. 
Antibodies:  Polyclonal  antibodies  against  human plasma fibronectin 
(anti-FN)  were generated  in  rabbits  (13). The  monoclonal  anti-fibroneetin 
antibody, IBl0, which blocks Chinese hamster ovary (CHO) cell attachment  to 
fibronectin,  has been described)  IgG from rabbits immunized with goat IgG 
was purchased  from Sigma Chemical  Co. The polyclonal antibody,  anti-FN, 
and the monoclonal antibody, IB 10, were affinity-purified before use, and along 
with the  rabbit  lgG,  were diluted  in  PBS containing  0.5% wt/vol BSA and 
0.025 M HEPES. 
Binding  of Antibodies  to  Fibronectin-coated  Nitrocellu- 
lose:  Pieces  of nitrocellulose ( 1 x  2 mm) coated with fibronectin  ( 177 ~tg/ 
ml) were washed three  times in PBS containing  0.5% wt/vol BSA and were 
then  incubated  in IBI0 or anti-FN  for 2 h at room temperature.  They were 
next washed four times in 0.154 M NaCl, three times in 0.154 M NaC1/0.05% 
vol/vol Tween 20 (including an overnight wash at 4*(7), and were then incubated 
in  the  appropriate  second  antibody  conjugated  to  horseradish  peroxidase 
(1:1,000 dilution  in PBS containing  0.5% wt/vol BSA and 0.05% Tween 20) 
for 30 min at 37"C. After extensive washing (eight times, including an overnight 
wash  at  4"C), in  NaC1/Tween,  an  o-phenylenediamine-H202  substrate  was 
added  (0.024 M citric acid, 0.053  M sodium phosphate,  0.04% vol/vol  30% 
H202, 0.04% wt/vol o-phenylenediamine),  and the reaction  was allowed to 
proceed for ~10 rain  after which it was stopped  with 2.5  M H2504, and the 
absorbance was read at 449 nm. Pieces of PBS-coated nitrocellulose included 
as controls were treated in an identical manner. 
Migration  on  Fibronectin-coated  Nitrocellulose  Treated 
with Antibodies:  Nitrocellulose pieces coated with fibronectin (177/~g/ 
ml) were washed three times in PBS containing  0.5% wt/vol BSA, and were 
then incubated  for 2 h  in IgG, anti-FN,  or IBI0 (see Results  for antibody 
concentrations).  After four 0.154 M NaCI washes, the pieces were placed into 
wounds,  and  10 h  later the amount of wound epithelium  on anti-FN-  and 
IBl0-treated  pieces was compared to the amount on those treated with IgG. 
RESULTS 
Migration on Nitrocellulose Coated with 
Fibronectin  or Fibronectin  Fragments 
In a preliminary experiment we found that a 2-min trypsin 
digest  of fibronectin  supported  as  much  migration  as  the 
intact molecule, indicating that further studies comparing the 
ability  of fibronectin fragments  to  support  migration  were 
feasible.  We therefore tested five proteolytically derived prep- 
arations of fibronectin (see  Fig.  2)  isolated as described  in 
Materials  and  Methods.  We  tested  the  following:  a  27-kD 
amino-terminal  heparin-binding fragment  (domain  I,  from 
both A and B chains of the molecule); a 46-kD gelatin-binding 
fragment  (domain II,  also  from  both chains); a  mixture of 
fragments originating from the middle of both chains (80- 
125 kD) with neither gelatin nor heparin affinity; a combined 
33- and 66-kD carboxy-terminal heparin-binding preparation 
representing the peptide  sequences  of domain  V  of the A 
chain and domains V and VI of the B chain, respectively;  and 
a 3 l-kD free sulfhydryl-containing fragment derived from the 
carboxy-terminal end of the A chain (domain VI). 
When  the  above  fragments  and  intact  fibronectin  were 
coated  onto nitrocellulose at  three different  concentrations 
(400,  100, and 25 #g/ml), the 80-125-kD mixture supported 
considerably more migration than any other fragment (Fig. 
3). For example, at 400 #g/ml, the 80-125-kD mixture pro- 
duced 50 units of migration above the amount occurring on 
control (PBS-coated)  nitrocellulose (shaded area  in Fig.  3). 
The  most  migration  produced by any other fragment  was 
only  l0 units above the control mean, a fivefold difference 
compared to the 80-125-kD mixture. At  100 and 25/zg/ml, 
the  80-125  kD  mixture  was  even  more  effective,  whereas 
migration on the other fragments  remained at or near control 
levels.  Not only was the  80-125  kD  mixture  clearly  more 
effective  than the other fragments,  but it was also  fully as 
effective as the intact molecule. (Statistical analysis ofthe data 
presented in this paragraph appears  in the legend accompa- 
nying Fig. 3.) 
Binding of Fibronectin  and Fibronectin  Fragments 
to Nitrocellulose 
To be sure that the difference in activity between the 80- 
125-kD fragments  and the others was not simply a reflection 
of fragment  affinity  for  nitrocellulose, we  radiolabeled  the 
various fragments,  applied them to nitrocellulose at 400 ~tg/ 
ml, and then, after extensive washing, assayed the amount of 
bound radioactivity. The percent of applied counts that bound 
ranged from 21  to 51% (Table I), with three of the inactive 
preparations showing a  binding efficiency  greater  than the 
80-125  kD mixture, which had the biological activity. The 
remaining inactive fragment (31 kD) bound with an efficiency 
comparable to the active  mixture.  Thus, the inactive frag- 
ments were not inactive because of insufficient protein on the 
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FIGURE  3  Epidermal cell  migration on  nitrocellulose coated with 
intact fibronectin fiN) or one of the fragment preparations described 
in Materials and Methods. Pieces of nitrocellulose were coated with 
the indicated materials by allowing 10 #] of a 400-,  100-, or 25-p,g] 
ml  solution to  dry  on  them  overnight.  After  washing  in  HS  that 
contained 5  mg/ml of BSA, the ability of the coated nitrocellulose 
to support epidermal migration was tested as described  in  Fig.  1. 
Each  point  represents,  at  400  t*.g/ml,  the  mean  for  at  least  16 
implants; at 100 #g/ml, at least 6; and at 25 ug/ml, at least 8. The 
shaded area represents the mean for control (PI3S coated) nitrocel- 
lulose  (n  =  66).  At each  concentration tested,  the  means for the 
80-125-kD  mixture and intact fibronectin were significantly higher 
than the control mean (p <  0.001  in all cases).  At each concentra- 
tion, the mean for the 80-125  kD mixture was significantly higher 
than the corresponding point for any other fragment (p <  0.005 in 
all cases), but was not significantly different from the corresponding 
mean for intact fibronectin (p =  0.4 or higher). No point on the four 
lower curves was significantly  higher than the control  mean (p  = 
0.2  or higher).  All p  values were determined  with  an  unpaired  t 
test. 
TABLE  I.  Binding of Fibronectin  Fragments to Nitrocellulose 
Counts  Counts re- 
Protein applied  applied  covered  Percent bound 
Fibronectin  22,600  6,200  27 
80-125 kD  22,900  5,100  22 
33/66 kD  16,000  6,600  41 
46 kD  19,000  7,900  42 
31  kD  50,400  10,700  21 
27 kD  27,400  14,000  51 
10 ~1 of tritium-labeled intact fibronectin or fibronectin fragments (400 ~,g/ 
ml) was dried onto 1- x 2-mm  rectangles of nitrocellulose.  Later, after the 
pieces of nitrocellulose  were washed extensively,  bound radioactivity was 
determined by scintillation  counting.  Counts applied and counts recovered 
represent the mean of triplicate samples. 
implants. 
The ability of fibronectin-coated nitrocellulose to support 
migration  was  better  when  100  ~g/ml  of fibronectin  was 
applied to the implant than when 400 tzg/ml was used (Fig. 
3).  This  behavior  on  nitrocellulose  may  be  related  to  its 
porosity. Thus, small amounts of unbound fibronectin leach- 
ing into  the  medium  from the depths of the implant may 
have inhibited migration by competing with bound fibronec- 
tin  for the  epidermal fibronectin receptor. A  precedent for 
this explanation has recently been provided by Yamada and 
Kennedy (3 l), who showed that soluble fibronectin and cer- 
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Lain synthetic fibronectin peptides could inhibit cell spreading 
on fibronectin-coated dishes.  Indeed, our binding studies us- 
ing radiolabeled materials showed that small amounts of label 
(1-6% of the amount bound) did leach into the medium from 
intact fibronectin and all fragments for several hours after the 
implants would  normally have been  placed in  the  wound. 
Thus, after the initial BSA treatment and a 30-min wash in 
HS, the amount of protein lost from each implant over the 
next 3.5 h was (for the 33/66-kD fragments) 0.07 ttg, (for the 
80-125 kD mixture) 0.05 ~g, (for the 31-kD fragment) 0.04 
ug, (for the 27-kD fragment) 0.03 ug, (for the 46-kD fragment) 
0.03  ug,  (for intact fibronectin) 0.01  ug,  most of this label 
coming off in the first hour.  Though this observation may 
account for the diminished effectiveness of the  80-125-kD 
active mixture and intact fibronectin at higher concentrations, 
the fact that these two forms of the molecule were at opposite 
ends of the range shows that there is no correlation between 
the amount of  protein lost and assignment of  a given fragment 
as active or inactive. 
Antibody Blocking Studies 
Since the position of the active sequence is between the 46- 
kD gelatin-binding fragment and a  66-kD carboxy-terminal 
end piece with an affinity for heparin (Fig. 2), the region of 
fibronectin with the greatest ability to support migration is in 
approximately the middle third of the molecule. To investi- 
gate  the  relationship  between  the  fibronectin  domain  that 
supports epidermal cell  migration and that which mediates 
the attachment of CHO cells,  we used IBl0, a  monoclonal 
antibody that  blocks CHO cell attachment to  fibronectin) 
Attempts to block epidermal migration on fibronectin-coated 
nitrocellulose using 55 ug/ml of IB10 were unsuccessful (Fig. 
4a),  despite the  fact that  this  amount  of antibody protein 
saturated the epitope it is directed against (Fig. 4 b). In con- 
trast,  a  polyclonal  anti-fibronectin  which  did  not  saturate 
implant-bound fibronectin at  55 vg/ml of antibody protein 
(Fig.  4b)  inhibited  migration  by  34%  when  used  at  this 
concentration, and by 80% when used at 400 ~g/ml (Fig. 4a). 
Thus, the region of the fibronectin molecule involved in CHO 
cell attachment may not be required for newt epidermal cell 
migration. 
DISCUSSION 
In previous studies  we  found  that  the  extracellular matrix 
proteins (fibrin[ogen], collagen, fibronectin,  and to a  lesser 
extent, laminin) all support amphibian epidermal cell migra- 
tion, whereas the nonmatrix proteins (serum albumin, fetuin, 
casein, and myoglobin) do not (3, 4, 5). Newt epidermal cells 
therefore,  show  a  distinct  specificity  in  their  response  to 
purified proteins as potential migration substrates. The pres- 
ent study now extends this specificity to fragments of fibro- 
nectin, in which the ability to support epidermal migration 
appears to be located primarily in an g0-125-kD sequence in 
the middle third of the molecule (Fig. 2). By contrast, a 27- 
kD amino-terminal peptide that binds heparin and Staphy- 
lococcus aureus, a 46-kD gelatin-binding peptide, a 33/66 kD 
carboxy-terminal  heparin-binding  preparation,  and  a  car- 
boxy-terminal 31-kD peptide were all unable or only margin- 
ally able to support epidermal cell migration. Since the 46- 
kD fragment (domain II) was found to be inactive, the active 
site is probably somewhere in domain III or IV, as depicted 
in Fig. 2. 80- 
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FIGURE  4  (A)  Epidermal cell  migration on  fibronectin-coated  nitrocellulose exposed to a  polyclonal anti-fibronectin  antibody 
(anti-FN),  or IB10, a  monoclonal anti-fibronectin  antibody that blocks attachment of CHO  cells to fibronectin.  After  pieces of 
nitrocellulose were individually exposed for 2  h to the indicated amounts of affinity-purified antibody protein, they were tested 
for their ability to support epidermal migration as described in Materials and Methods and the legend to Fig.  1. The mean values 
obtained for the relative distance migrated in each group was used to determine % inhibition according to the following formula: 
mean for polyclonal- or monoclonal-treated 
1 -  x  100. 
mean for  IgG-treated (400 ~tg/ml} 
In all cases, n =  8 or 9. P values were derived from unpaired t tests of the migration means for each group compared to the mean 
for IgG. (B) Binding curve of polyclonal anti-fibronectin (anti-FN)  and the anti-fibronectin monoclonal, IB10, to fibronectin-coated 
pieces of nitrocellulose. After a 2-h exposure to anti-FN or IB10, the nitrocellulose was treated with a second antibody conjugated 
to horseradish peroxidase. Binding was visualized by exposure to an o-phenylenediamine-hydrogen peroxide substrate and the 
absorbance was read at 449 nm.  Each  point  represents the mean of duplicate or triplicate samples minus  the corresponding 
values for anti-FN- or IB10-treated nitrocellulose not coated with fibronectin. 
Though the active domain may also contain the attachment 
site for CHO cells, our antibody blocking studies suggest that 
the site supporting epidermal cell migration may be separate 
and distinct from the CHO binding site. This possibility  is 
based on experiments in which IB10, a monoclonal antibody 
that  potently inhibits  CHO cell  attachment  to fibronectin- 
coated dishes when used at the same concentration as in the 
present study,~ failed to inhibit epidermal migration. Sensitiv- 
ity of the migration system to antibody blockade was dem- 
onstrated when  implants pretreated  with a  polyclonal anti- 
fibronectin showed a diminished ability to support migration. 
Thus, at 55 #g/ml, the polyclonal antibody produced a 34% 
inhibition of migration, and at 400 jzg/ml, an 80% inhibition, 
suggesting  near-saturation  of the  active  site  at  the  higher 
concentration.  In  contrast,  treatment  of fibronectin-coated 
implants with 55 ~zg/ml of IB10, a concentration well above 
the minimum amount needed for saturation of  the fibronectin 
epitope against  which this monoclonal antibody is directed, 
had no effect on migration. 
The epitope that binds IB10 is not the same as that binding 
3E3, a  monoclonal antibody derived by Pierschbacher et al. 
(22) which blocks NRK cell attachment to fibronectin. This 
was shown when immunoelectroblots of thermolysin digests 
of fibronectin revealed  similar but not identical  binding pat- 
terns with IBl0 and 3E3.' Furthermore, IBl0 does not react 
with  the  I 1.5-kD  NRK cell attachment peptide purified by 
Pierschbacher et al.' (22). This could mean that IB l0 blocks 
one attachment site  and  3E3  blocks another.  Alternatively, 
these monoclonal antibodies may block the same site, one or 
both acting by steric hindrance. If  they block different  attach- 
ment sites, then the site which supports epidermal cell migra- 
tion could be the same one that mediates NRK cell attach- 
ment. If both monoclonal antibodies block the same site, as 
seems  likely, and the epidermal-IB10 results  are accepted at 
face value, then the epidermal migration site would be unre- 
lated to either CHO or NRK cell attachment. Since embryonic 
chick neurons will attach and extend neurites on tissue culture 
plastic coated with the 33/66-kD heparin-binding fragments 
of fibronectin (23), this would not be the first instance of a 
cell-binding  region  unrelated  to  the  attachment  sequence 
described  by Pierschbacher et al. (22). We should point out 
however, that in the epidermal migration system described  in 
the present study, certain modifying molecules (proteins,  gly- 
coproteins, glycosaminoglycans, etc.)  that are  normal com- 
ponents of the wound environment may be involved in the 
interaction of newt epidermal cells with the fibronectin mol- 
ecule. Despite the fact that the known binding sites for hepa- 
rin, collagen, and fihrin(ogen)  are excluded from the 80-125 
kD  sequence  (Fig. 2),  a  wound-derived mediator  may yet 
prove to be involved in newt epidermal cell migration over 
fibronectin-coated substrates.  Should  this  be  the  case,  the 
active  site  which  promotes epidermal  cell  migration  might 
simply represent an amino acid sequence that binds a migra- 
tion-supporting wound macromolecule. Whatever the mech- 
anism involved, we have shown that within domain III or IV 
of human plasma fibronectin, there is a sequence which not 
only mediates the initial  attachment of epidermal cells in a 
semi-in vivo system,  but allows those cells to engage in the 
DONALDSON ET AL  Fibronectin and Epidermal Cell Migration  77 multiple cycles of adhesion  and  de-adhesion  necessary  for 
orderly cell movement. 
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